PURA - Puration Pursues M&A Strategy in Cannabis Consolidation Market
January 29 2020 - 12:36PM
InvestorsHub NewsWire
PURA – Puration Pursues M&A
Strategy in Cannabis Consolidation Market
Dallas, TX -- January 29, 2020 -- InvestorsHub NewsWire --
Puration, Inc. (USOTC:
PURA) today announced plans to further pursue the prevailing
cannabis consolidation market opportunity by acquiring smaller
cannabis infusion companies. Multiple cannabis investment
market analysts have forecasted a market wide consolidation as
larger cannabis sector firms acquire smaller firm. PURA has
built expertise and resources to infuse cannabis into beverages and
is now looking to expand the capacity to include food infusion
capacity. PURA is currently exploring the acquisition of
Kali-Extracts’ (USOTC:
KALY) CBD confections business. PURA management now
confirms that the company is also exploring additional acquisition
opportunities. PURA currently produces the leading CBD
beverage in the sports nutrition market, EVERx CBD Sports
Water. EVERx now has distribution in Europe, Latin America
and Africa in addition to within the United States. PURA
management believes the company is well staged for acquiring and
growing additional cannabis infused beverages and foods.
For more information on Puration, visit http://www.purationinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur. These statements have not been evaluated
by the Food and Drug Administration. These products are not
intended to diagnose, treat, cure, or prevent any
disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Sep 2023 to Sep 2024